The purpose of this study is to test the utilization of incentive values (considerably lower than those typically used in research clinics) to motivate clients to attend treatment and initiate and sustain abstinence.

Condition	Treatment or Intervention	Phase
Substance-Related Disorders	Behavior: Behavior Therapy	Phase III

Further Study Details: 

Expected Total Enrollment:  390

The purpose of the proposed research is to implement and systematically evaluate, in community treatment settings, motivational incentive procedures that have been well researched and have proven efficacious in a variety of treatment research clinics. The study will determine if motivational incentives along with standard care therapy is more effective than standard therapy alone for the treatment of patients using cocaine or methamphetamine and entering a substance abuse treatment program.

Ages Eligible for Study:  18 Years and above,  Genders Eligible for Study:  Both

Criteria

Inclusion Criteria:

1. Recent admission to an opioid substitution (methadone maintenance) CTP. Completed at least 4 weeks of maintenance at time of study entry

2. Evidence of cocaine or methamphetamine use Minimum of one documented positive urine within 2 weeks of study entry. For those exiting a controlled environment, any stimulant use within two weeks of entering the controlled environment

Exclusion Criteria:

1. Unable to give informed consent (fails simple consent quiz)

2. Answers yes to question: Are you in recovery from gambling? That is, have you stopped gambling because of previous gambling problems?

California
      Aegis Medical Systems, Inc., Bakersfield,  California,  93301 4709,  United States
District of Columbia
      Oasis Clinic, Washington,  District of Columbia,  20002,  United States
Maryland
      Glenwood Life Counseling Center, Baltimore,  Maryland,  21212,  United States
New York
      Lower Eastside Service Center (LESC), New York,  New York,  10007,  United States
      Greenwich House, Inc., New York,  New York,  10014,  United States
Pennsylvania
      ACT, Philadelphia,  Pennsylvania,  19141,  United States
South Carolina
      Charleston Center, Charleston,  South Carolina,  29403,  United States

Study chairs or principal investigators

Maxine Stitzer, Ph.D.,  Principal Investigator,  Johns Hopkins University   

Study ID Numbers:  NIDA-CTN-0007-1
Record last reviewed:  May 2004
Last Updated:  February 16, 2005
Record first received:  April 5, 2002
ClinicalTrials.gov Identifier:  NCT00033020
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-04-08